Frontotemporal Dementia (FTD) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By Delveinsight

Posted on
by

Frontotemporal Dementia (FTD) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By Delveinsight

DelveInsight Busines Research LLP
DelveInsight’s ” Frontotemporal Dementia – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Frontotemporal Dementia, historical and forecasted epidemiology as well as the Frontotemporal Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Frontotemporal Dementia (FTD) – Market Insights, Epidemiology, and Market Forecast-2030

DelveInsight’s “Frontotemporal Dementia (FTD) – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the  Frontotemporal Dementia (FTD), historical and forecasted epidemiology as well as the  Frontotemporal Dementia (FTD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. As per the study the prevalence of FTD between the ages of 45–65 years ranged from 15 to 22 per 100,000 people, with incidence estimates ranging from 2.7 to 4.1 per 100,000 members in the same age range.

  2. As per the National Organization for Rare Disorder 2019, Frontotemporal degeneration is the second most common form of dementia in people under the age of 65 after Alzheimer’s disease. The mean age of onset is usually given at the late 50s, with an age range of 20–80. However, onset before 40 or after 75 is less common.

  3. As per Chiadikaobi U Onyike et al. 2013, Frontotemporal dementia, a heterogeneous neurodegenerative disorder, is a common cause of young onset dementia. The estimated point prevalence was 15–22 per 100,000 and Prevalence 2.7–4.1 per 100,000. Some 25% are late-life onset cases.

Key benefits of the report:

1.  Frontotemporal Dementia (FTD) market report covers a descriptive overview and comprehensive insight of the  Frontotemporal Dementia (FTD) epidemiology and  Frontotemporal Dementia (FTD) market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.  Frontotemporal Dementia (FTD) market report provides insights on the current and emerging therapies.

3.  Frontotemporal Dementia (FTD) market report provides a global historical and forecasted market covering drug outreach in 7 MM.

4. The  Frontotemporal Dementia (FTD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the  Frontotemporal Dementia (FTD) market.

Request for sample pages: https://www.delveinsight.com/sample-request/frontotemporal-dementia-market

Frontotemporal Dementia (FTD): Overview

Frontotemporal dementia (FTD) is an umbrella term for a diverse group of uncommon disorders that primarily affect the frontal and temporal lobes of the brain areas. In this disorder, portions of these lobes shrink (atrophy). The degeneration of the frontotemporal lobe is primarily triggered due to proteins involvement TDP43 and tau, which directly outbreaks the damage on the temporal and frontal lobes of the brain.

The key player involved in Frontotemporal Dementia (FTD) market:

  1. TauRx Therapeutics

  2. Alector

  3. Neurimmune/ Biogen

The launch of the emerging therapies is expected to significantly impact the  Frontotemporal Dementia (FTD) treatment scenario in the upcoming years:-

Drugs covered

  1. LMTX

  2. AL001

  3. NI205

Request a free sample report @https://www.delveinsight.com/sample-request/frontotemporal-dementia-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4.  Frontotemporal Dementia (FTD) Patient Share (%) Overview at a Glance

5.  Frontotemporal Dementia (FTD) Market Overview at a Glance

6.  Frontotemporal Dementia (FTD) Disease Background and Overview

7.  Frontotemporal Dementia (FTD) Epidemiology and Patient Population

8. Country-Specific Patient Population of  Frontotemporal Dementia (FTD)

9.  Frontotemporal Dementia (FTD) Current Treatment and Medical Practices

10. Unmet Needs

11.  Frontotemporal Dementia (FTD) Emerging Therapies

12.  Frontotemporal Dementia (FTD) Market Outlook

13. Country-Wise  Frontotemporal Dementia (FTD) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18.  Frontotemporal Dementia (FTD) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Frontotemporal Dementia (FTD)- Pipeline Insights, 2021

” Frontotemporal Dementia (FTD) Pipeline Insight, 2021″ report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the  Frontotemporal Dementia (FTD) market. A detailed picture of the  Frontotemporal Dementia (FTD) pipeline landscape is provided, which includes the disease overview and  Frontotemporal Dementia (FTD) treatment guidelines.

Frontotemporal Dementia (FTD)- Epidemiology Forecast 2030

DelveInsight’s ‘ Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted  Frontotemporal Dementia (FTD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/